Compass Therapeutics, Inc.

Pages

Compass Therapeutics, Inc.

$CMPX

Search Table
Pages

Trade Date Insider Title Buy or Sell Quantity Security Type Price Proceeds Transaction Conviction Position Quantity Position Value Positon Conviction SEC Link Nature of Ownership
2021-06-25Miranda Jayne Toledano-Buy1,791,549Common Stock, $.0001 Par Value$0.00$0.00  -1,791,549$0.00  349.14   [Very High]Form 4-
2021-11-04Advisors Llc Orbimed-Buy1,785,715Common Stock$3.50-$6,250,002.50  183.32   [ Very High ]14,500,119$50,750,416.50  1,488.57 [Very High]Form 4See Footnotes
2021-11-04Advisors Llc Orbimed-Buy3,571,428Common Stock$3.50-$12,499,998.00  366.64   [ Very High ]3,571,428$12,499,998.00  366.64   [Very High]Form 4See Footnotes
2021-11-04Carl L Gordon-Buy1,785,715Common Stock$3.50-$6,250,002.50  183.32   [ Very High ]14,500,119$50,750,416.50  1,488.57 [Very High]Form 4See Footnotes
2021-11-04Carl L Gordon-Buy3,571,428Common Stock$3.50-$12,499,998.00  366.64   [ Very High ]3,571,428$12,499,998.00  366.64   [Very High]Form 4See Footnotes
2021-11-16Vered Bisker-leibChief Operating OfficerBuy600,000Common Stock$0.00$0.00  -1,113,401$0.00  113.58   [Very High]Form 4-
2022-05-06Advisors Llc Orbimed-Buy10,200Common Stock$1.63-$16,626.00  1.01     [ High ]14,510,319$23,651,819.97  1,432.37 [Very High]Form 4See Footnotes
2022-05-09Advisors Llc Orbimed-Buy90,712Common Stock$1.56-$141,510.72  8.95     [ Very High ]14,601,031$22,777,608.36  1,441.32 [Very High]Form 4See Footnotes
2022-05-10Advisors Llc Orbimed-Buy24,447Common Stock$1.60-$39,115.20  2.41     [ High ]14,625,478$23,400,764.80  1,443.74 [Very High]Form 4See Footnotes
2022-05-06Carl L Gordon-Buy10,200Common Stock$1.63-$16,626.00  1.01     [ High ]14,510,319$23,651,819.97  1,432.37 [Very High]Form 4See Footnotes
2022-05-09Carl L Gordon-Buy90,712Common Stock$1.56-$141,510.72  8.95     [ Very High ]14,601,031$22,777,608.36  1,441.32 [Very High]Form 4See Footnotes
2022-05-10Carl L Gordon-Buy24,447Common Stock$1.60-$39,115.20  2.41     [ High ]14,625,478$23,400,764.80  1,443.74 [Very High]Form 4See Footnotes
2022-05-10Thomas J. SchuetzCHIEF EXECUTIVE OFFICERBuy27,836Common Stock$1.80-$50,104.80  2.75     [ Very High ]5,153,303$9,275,945.40  508.70   [Very High]Form 4-
2022-05-11Advisors Llc Orbimed-Buy64,700Common Stock$1.79-$115,813.00  6.39     [ Very High ]14,690,178$26,295,418.62  1,450.37 [Very High]Form 4See Footnotes
2022-05-12Advisors Llc Orbimed-Buy97,094Common Stock$2.35-$228,170.90  9.59     [ Very High ]14,787,272$34,750,089.20  1,459.95 [Very High]Form 4See Footnotes
2022-05-13Advisors Llc Orbimed-Buy30,722Common Stock$2.49-$76,497.78  3.03     [ Very High ]14,817,994$36,896,805.06  1,462.99 [Very High]Form 4See Footnotes
2022-05-11Carl L Gordon-Buy64,700Common Stock$1.79-$115,813.00  6.39     [ Very High ]14,690,178$26,295,418.62  1,450.37 [Very High]Form 4See Footnotes
2022-05-12Carl L Gordon-Buy97,094Common Stock$2.35-$228,170.90  9.59     [ Very High ]14,787,272$34,750,089.20  1,459.95 [Very High]Form 4See Footnotes
2022-05-13Carl L Gordon-Buy30,722Common Stock$2.49-$76,497.78  3.03     [ Very High ]14,817,994$36,896,805.06  1,462.99 [Very High]Form 4See Footnotes
2022-05-17Thomas J. SchuetzCHIEF EXECUTIVE OFFICERBuy20,215Common Stock$2.47-$49,931.05  2.00     [ High ]5,173,518$12,778,589.46  510.79   [Very High]Form 4-